With 42% of all deaths in the US ending with some form of hospice care and demand for the service growing by the day, espousing a contrarian viewpoint one of the industry's largest for-profit providers may appear senseless. Chemed's (NYSE:CHE) intimidating 1.4B market cap currently trades at 19x ttm EPS, and valued at 6x forward earnings estimates. The stock price is up 17% in the last four months, and 51% in the last 3 years. This industry powerhouse has consistently beat consensus estimates over the last six quarters by an average shy of 3%.
The company is best known for its two unrelated segments. The hospice division Vitas, and Roto Rooter, the largest provider of plumbing repair, sewer...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|